Research & Education
Cancer Can't Win
The purpose of this research is to study a vaccine treatment called recombinant canarypox-NY-ESO-1/TRICOM [also called ALVAC(2)-NY-ESO(M)/TRICOM]. The study is limited to patients with epithelial ovarian, fallopian tube or primary peritoneal carcinoma whose tumors express certain proteins (antigens) called NY-ESO-1 or LAGE-1. A vaccine is a medicine that teaches the immune system in the body to destroy harmful infections or cancer cells that do not belong in the normal tissues.
Please Click on link for ClinicalTrials.gov for eligibility criteria.